Lista de obras -

90K (Mac-2 BP) and galectins in tumor progression and metastasis

artículo científico publicado en 2004

A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression

scientific article published on 03 July 2019

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

artículo científico publicado en 2016

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

artículo científico publicado en 2017

Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib

scientific article published on 16 March 2020

An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors

artículo científico

Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.

artículo científico publicado en 2015

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

artículo científico publicado en 2018

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey

artículo científico publicado en 2014

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

artículo científico publicado en 2013

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study

artículo científico publicado en 2014

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

scientific article published on 18 November 2019

Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer

artículo científico publicado en 2013

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

scientific article published on 22 February 2019

Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

artículo científico publicado en 2019

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

scientific article published on 21 February 2019

Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation"

artículo científico publicado en 2020

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

artículo científico publicado en 2019

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

scientific article published on 15 November 2019

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials

artículo científico publicado en 2018

Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review

artículo científico publicado en 2015

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

artículo científico publicado en 2013

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

scientific article published on 12 October 2019

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

artículo científico publicado en 2020

Expression of the 90K Tumor-Associated Protein in Benign and Malignant Melanocytic Lesions

scientific article published on 01 July 2002

FPSE-HPLC-DAD method for the quantification of anticancer drugs in human whole blood, plasma, and urine

artículo científico publicado en 2018

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.

artículo científico publicado en 2017

High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies

scientific article published on 01 January 2009

Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey

artículo científico publicado en 2014

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

artículo científico publicado en 2020

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

artículo científico publicado en 2019

Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody

artículo científico publicado en 2014

Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?

artículo científico publicado en 2015

Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.

artículo científico publicado en 2017

Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.

artículo científico publicado en 2014

Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice

artículo científico publicado en 2012

Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer

artículo científico publicado en 2008

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

artículo científico

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

artículo científico publicado en 2018

Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study

scientific article published on 13 December 2019

Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma

artículo científico publicado en 2020

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

artículo científico publicado en 2019

Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer.

artículo científico publicado en 2007

Reply to Kadri Altundag: Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage?

artículo científico publicado en 2017

Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells

artículo científico publicado en 2014

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies

artículo científico publicado en 2013

The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides

artículo científico publicado en 2004

The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer

artículo científico publicado en 2019

The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function

artículo científico publicado en 2014

Tumor-derived microvesicles: the metastasomes.

artículo científico publicado en 2012

Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein.

artículo científico publicado en 2007

Lista de obras de

90K (Mac-2 BP) and galectins in tumor progression and metastasis

A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib

An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors

Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation"

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials

Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

Expression of the 90K Tumor-Associated Protein in Benign and Malignant Melanocytic Lesions

FPSE-HPLC-DAD method for the quantification of anticancer drugs in human whole blood, plasma, and urine

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.

High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies

Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody

Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?

Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.

Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.

Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice

Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study

Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer.

Reply to Kadri Altundag: Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage?

Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies

The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides

The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer

The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function

Tumor-derived microvesicles: the metastasomes.

Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein.